Latest article
Discover new trends, cutting-edge technologies, and outstanding activities in the fields of testing, molecular biology, and laboratory solutions.
-
HUMAN PHOSPHORYLATED TAU217 DETECTION KIT – THE BREAKTHROUGH NON-INVASIVE ALZHEIMER’S EARLY SCREENING SOLUTION
In the pathological progression of Alzheimer’s Disease (AD), plasma p-Tau217 is proven to be the most specific and earliest detectable biomarker. Capturing this biomarker allows healthcare providers to identify neurodegenerative pathology 10...
-
Unveiling Tau and Amyloid-beta: The Biological Footprints Transforming Early Alzheimer’s Diagnosis
Alzheimer’s disease remains one of the most formidable medical challenges of our time, serving as the leading cause of dementia worldwide. A critical bottleneck in patient care is that by the time...
-
INSPIRER DX ANALYZER – THE BREAKTHROUGH SINGLE-MOLECULE IMMUNOASSAY PLATFORM
In the era of precision medicine, ultra-low detection of biomarkers is the golden key to transforming clinical outcomes. Moving far beyond the constraints of traditional screening methods, the Inspirer DX Analyzer utilizes...
-
Why Waiting for Alzheimer’s Symptoms is Too Late: The Golden Power of Preclinical Biomarkers
When most people think of Alzheimer’s disease, they envision an elderly individual struggling to find their way home or a parent looking blankly at their own child, unable to recall their name....
-
DOIT SCIENTIFIC JSC MAKES A POWERFUL IMPACT AT VIETNAM MEDI-PHARM 2026: USHERING IN A NEW ERA OF ALZHEIMER’S SCREENING
The Vietnam International Medical & Pharmaceutical Exhibition (Vietnam Medi-Pharm 2026) has officially concluded, marking a journey of extraordinary success and inspiration for DOIT Scientific JSC. At this year’s event, we did not...
-
[EVENT] A MEDICAL FIRST IN VIETNAM: DOIT SCIENTIFIC UNVEILS 10-20 YEAR EARLY ALZHEIMER’S SCREENING TECHNOLOGY AT MEDI-PHARM 2026
Dear Esteemed Partners, Healthcare Professionals, and Clients, As part of the Vietnam International Medical & Pharmaceutical Exhibition (Vietnam Medi-Pharm 2026), DOIT Scientific JSC is marking a historic milestone by bringing blood-based early...